VECURONIUM BROMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vecuronium Bromide, and when can generic versions of Vecuronium Bromide launch?
Vecuronium Bromide is a drug marketed by Eugia Pharma, Gland, Hikma, Hospira, Meitheal, Mylan Labs Ltd, Sagent Pharms Inc, Sun Pharm, and Watson Labs. and is included in twelve NDAs.
The generic ingredient in VECURONIUM BROMIDE is vecuronium bromide. There are six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the vecuronium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vecuronium Bromide
A generic version of VECURONIUM BROMIDE was approved as vecuronium bromide by MEITHEAL on August 25th, 1999.
Summary for VECURONIUM BROMIDE
US Patents: | 0 |
Applicants: | 9 |
NDAs: | 12 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 84 |
Clinical Trials: | 12 |
Patent Applications: | 1,814 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VECURONIUM BROMIDE at DailyMed |
Recent Clinical Trials for VECURONIUM BROMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The Second Affiliated Hospital of Harbin Medical University | Phase 4 |
Ningbo No. 1 Hospital | Phase 4 |
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University | Phase 4 |
Pharmacology for VECURONIUM BROMIDE
Drug Class | Nondepolarizing Neuromuscular Blocker |
Physiological Effect | Neuromuscular Nondepolarizing Blockade |
Medical Subject Heading (MeSH) Categories for VECURONIUM BROMIDE
Anatomical Therapeutic Chemical (ATC) Classes for VECURONIUM BROMIDE
US Patents and Regulatory Information for VECURONIUM BROMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eugia Pharma | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 206670-001 | Dec 20, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sagent Pharms Inc | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 078274-001 | Dec 29, 2008 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hikma | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 203725-001 | Jul 30, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Gland | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 205390-002 | May 26, 2016 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hospira | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 075164-001 | Oct 21, 1999 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |